In addition, in 384 patients with non-small-cell lung cancer, the incidence of brain metastases was 49.5% among patients with L858R EGFR-mutated cancer versus 27.3% among those with wild-type cancer [60]. This evidence concerns the gene EGFR and non-small cell lung carcinoma.